Aerie Pharmaceuticals, Inc. (AERI)
Shares of AERI soared more than 70% in the extended session Wednesday after the company reported the successful results of its second Phase 3 trial for Rhopressa(TM), a novel once-daily, triple-action eye drop being tested for its ability to lower intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.
According to AERI, the trial achieved its primary efficacy endpoint demonstrating non-inferiority of Rhopressa compared to timolol, the most widely used comparator, and the Rocket 2 efficacy results for the company’s glaucoma treatment demonstrated a consistent level of IOP lowering across all baseline IOPs and throughout the 90-day efficacy period.
AERI looks forward to its Rocket 2 safety results expected at the end of 2015 or early 2016. Based on its previous discussions with the FDA, AERI said it expects to file its Rhopressa NDA in mid-2016.
AERI is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
More about Aerie Pharmaceuticals, Inc. (AERI) at www.aeriepharma.com
Herman Miller, Inc. (MLHR)
MLHR shares surged over 7% in after-hours trading Wednesday as the company delivered stronger-than-expected quarterly financial results.
For its first quarter fiscal 2016, MLHR posted net sales of $565.4 million, a 10.9% increase year over year, and net earnings of $0.56 per diluted share, compared to net earnings of $0.42 per diluted share in the same quarter the prior year, topping the Capital IQ Consensus Estimate of $0.47 earnings per share on revenues of $554.35 million for the period
MLHR expects net sales for the second quarter fiscal 2016 to be in the range of $570 million to $590 million and diluted earnings per share are expected to range between $0.52 and $0.56 for the period.
In addition to its classic pieces and new designs for the home, MLHR is a recognized innovator in contemporary interior furnishings, solutions for healthcare environments, and related technologies and services.
More about Herman Miller, Inc. (MLHR) at www.hermanmiller.com
Crown Equity Holdings Inc. (CRWE)
CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.
The company is currently developing its CRWE WORLD ( www.crweworld.com ), a community targeted platform which goal is to be a one-stop shop for the various needs of online consumers in a range of marketing specialties like Real Estate, Coupons & Deals, Business Directory and more
CRWE WORLD’s business model is based on selling advertising to businesses targeting their marketing message locally, nationally, internationally and also to target potential clients for an specific location, such as within a certain zip code.
Roxzu ( www.roxzu.com ) in development stage, is an on-line e-commerce coupon distribution channel and marketplace for merchants to create brand awareness for their business. The geo-location based mobile marketing application Roxzu is expected to be integrated in all the CRWE WORLD Network.
More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE PR Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE PR Finance www.finance.crwe-pr.com/disclaimer